FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23369 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Nervous system disorders NOS Disorder of nervous system (disorder)
Nervous system disorders NOS Disorder of nervous system (disorder)
Nervous system examination depth NOS Neurological observable
Nervous system examination depth NOS Depth of nervous system examination (situation)
Nervous system operations NOS Operation on nervous system
Nervous system operations NOS Operation on nervous system
Nesochen sandvicensis Branta sandvicensis (organism)
Nettle rash Urticaria
NeuRobot Robot
Neuralgia Neuralgia
Neurinomatosis Melanotic schwannoma
Neurocutaneous melanosis sequence Neurocutaneous melanosis
Neuroectodermal endocrine syndrome Woodhouse Sakati syndrome
Neurofibramatosis 3 Full schwannomatosis
Neurofibroma, no International Classification of Diseases for Oncology subtype Benign neurofibroma
Neurofibromatosis type 3 Full schwannomatosis
Neurol. diag. proced. - NOS Procedure on nerve
Neurol. diag. proced. - NOS Procedure on nerve
Neuroleptic malignant syndrome Neuroleptic malignant syndrome
Neurologic myelopathy-retired Spinal cord disorder (disorder)
Neurological disorder caused by ingestible alcohol Neurological disorder caused by ethanol (disorder)
Neurological disorder monitoring NOS Neurological disorder monitoring
Neurological disorder monitoring NOS Neurological disorder monitoring
Neurological monitoring NOS Neurological monitoring regime (regime/therapy)
Neurological monitoring NOS Neurological monitoring regime (regime/therapy)
Neurological status not worse than preoperative baseline Neurological status is consistent with or improved from preoperative baseline (finding)
Neurological/special sense screening NOS Neurological/special sense screening
Neurological/special sense screening NOS Neurological/special sense screening
Neurology service Neurology service
Neurolysis - action Destruction - action
Neurolytic techniques Destructive procedure of nerve
Neuroma (excl. acoustic) Neuroma (disorder)
Neuroma (excluding acoustic) Neuroma (morphologic abnormality)
Neuroma - category Neuroma (morphologic abnormality)
Neuroma, no International Classification of Diseases for Oncology subtype Neuroma (morphologic abnormality)
Neuromuscular diagnostic procedure Neuromuscular procedure
Neuromuscular transmission drug Skeletal muscle relaxant (substance)
Neuromyositis-retired Polymyositis
Neuropathic impotence Erectile dysfunction due to neuropathy
Neuroplasty NOS Neuroplasty
Neuroradiography with contrast abnormal Computed tomography of nervous system with contrast abnormal (finding)
Neuroradiography with contrast normal CT of nervous system with contrast normal
Neuroses or other mental disorder NOS Mental disorder
Neurotic, personality and other nonpsychotic disorders Mental disorder
Neurovascular island sensory skin flap NEC Neurovascular island sensory skin flap
Neutral epinephrine 0.05% eye drops Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution
Neutral epinephrine 0.1% eye drops Adrenaline 1 mg/mL eye solution
Neutral epinephrine 0.25% eye drops Adrenaline 2.5 mg/mL eye solution
Neutral epinephrine 0.5% eye drops Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution
Neutron Neutron
Nevirapine 50mg/5mL suspension Product containing precisely nevirapine 10 milligram/1 milliliter conventional release oral suspension (clinical drug)
Nevus atrophicus Melanocytic nevus (disorder)
New partial retinal detachment with multiple defects Partial detachment of retina with multiple breaks of retina (disorder)
New patient screening NOS New patient screening status
New patient screening NOS New patient screening
New patient screening administration NOS New patient screening
New sexual contact New sexual contact (finding)
Newborn physiological jaundice NOS Newborn physiological jaundice
Nicardipine hydrochloride 60mg m/r capsule Nicardipine only product in oral dose form
Nicardipine hydrochloride 60mg prolonged-release oral capsule Nicardipine only product in oral dose form
Nicardipine m/r capsule Nicardipine only product in oral dose form
Nicotine 10mg inhalator refill pack Nicotine only product
Nicotine 10mg inhalator starter pack Nicotine only product
Nicotine 10mg inhaler Nicotine only product
Nicotine 11mg/24hours patch Nicotine 458 microgram/hour prolonged-release transdermal patch
Nicotine 22mg/day patch Product containing precisely nicotine 917 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Nicotine dependence with current use Nicotine dependence (disorder)
Nicotine replacement therapy provided free Nicotine replacement therapy
Nicotine replacement therapy provided free Nicotine replacement therapy
Nicotine replacement therapy provided free Nicotine replacement therapy
Nicotine stomatitis Leukokeratosis nicotina palati
Nicotinic acid 375mg m/r tablet and nicotinic acid 500mg m/r tablet and nicotinic acid 750mg m/r tablet starter pack Nicotinic acid only product in oral dose form
Nicotinic acid 375mg prolonged-release oral tablet Nicotinic acid only product in oral dose form
Nifedipine 90mg m/r tablet Product containing only nifedipine in oral dose form (medicinal product form)
Nifedipine 90mg prolonged-release oral tablet Product containing only nifedipine in oral dose form (medicinal product form)
Nimodipine 200micrograms/mL infusion solution 50mL vial Product containing precisely nimodipine 200 microgram/1 milliliter conventional release solution for injection (clinical drug)
Nine previous induced terminations of pregnancy Past pregnancy history of multiple induced termination of pregnancy
Nipple discharge NOS Nipple discharge symptom
Nipple discharge NOS Nipple discharge symptom
Nisoldipine 40mg m/r tablet Nisoldipine only product in oral dose form
Nisoldipine 40mg prolonged-release oral tablet Nisoldipine only product in oral dose form
Nitroderivatives and aminoderivatives of benzene and its homologues Benzene derivative hydrocarbon
Nitroglycerin 2.5mg Glyceryl trinitrate 2.5 mg oral capsule
No FH: NOS No family history of
No active range of ankle extension No active range of ankle plantar flexion (finding)
No active range of ankle flexion No active range of ankle dorsiflexion (finding)
No alcohol abuse No evidence of alcohol use disorder (situation)
No antenatal care NOS No antenatal care
No antenatal care NOS No antenatal care
No diagnosis on Axis I Psychological finding
No diagnosis on Axis II Psychological finding
No diagnosis on Axis III Psychological finding
No diagnosis on Axis IV Psychological finding
No diagnosis on Axis V Psychological finding
No family history: NOS No family history of
No follow-up NOS No follow-up arranged
No follow-up NOS No follow-up arranged
No known allergies No known allergy (situation)
No living organism identified No living organism identified (finding)
No pT1 category, insufficient tissue (prostate) American Joint Committee on Cancer pT2 (qualifier value)
No passive range of ankle extension No passive range of ankle plantar flexion

Start Previous Page 122 of 234 Next End


Reference Sets

Reference set descriptor

Back to Start